CPC-024 Assessment of Ward-Based Clinical Pharmacy Services in Jimma University Specialist Hospital, Ethiopia: The Case of Internal Medicine. (12th March 2013)

• Record Type: Journal Article
• Authors: Berhane, A; Ali, E; Peggy, O; Suleman, S
• Is Part Of: European journal of hospital pharmacy. Volume 20(2013)Supplement 1
• Page Start: A174
• Page End: A174
• Publication Date: 2013-03-12
• Subjects: Pharmacy -- Periodicals; Hospital pharmacies -- Periodicals; 615.1
• DOI: 10.1136/ejhpharm-2013-000276.481
• Languages: English
• ISSNs: 2047-9956

Abstract

Abstract : Background: Patient-centred clinical pharmacy practise has developed internationally to expand the role of a pharmacist well beyond the traditional roles of compounding, dispensing and supplying drugs, though it is poorly developed in Africa. Implementation of patient-centred practise is an important goal for maximising the utility of the profession. But, studies on the work done by pharmacists in inpatient wards in resource-constrained settings are scarce. Purpose: To assess ward-based clinical pharmacy services in an internal medicine ward of Jimma University Specialist Hospital. Materials and Methods: The study was carried out on the internal medicine ward from March to April, 2011 at Jimma University Specialist Hospital. It was a prospective observational study. Clinical pharmacy interns providing pharmaceutical care to inpatients twice per week over a 2-month period were documented. Interventions optimising rational drug use and their acceptance were recorded. The clinical significance of interventions was evaluated by an independent team (1 internist, 1 pharmacologist). Results of the study were reported in the form of findings and percentages. Results: A total of 149 drug-related interventions for 48 patients was documented. Of these, 133 (89.3%) were clinical pharmacy intern-initiated interventions and 16 (10.7%) were interventions initiated by another health care professional. The most frequent drug-related problems (DRPs) underlying interventions were unnecessary drug treatment 36 (24.2%), additional drug treatment needed 34 (22.8%) and noncompliance 29 (19.5%). The most frequent type of intervention was change of dose/instruction for use, 23 (15.4%). 68.4% of interventions were fully accepted and 29.3% were partially accepted. Interventions with major and moderate clinical significance numbered 46 (49.5%) and 25 (26.9%) respectively. Conclusions: A clinical pharmacist contributes to improved inpatient treatment, even with a modest contribution such as participation in the pre-round meeting and the ward round twice per week. No conflict of interest.